Ion channels represent a key target class for therapeutics to treat human disease. The prevalence of debilitating pain disorders and…
Read MoreYour search results
Showing 1–12 of 280 results
Qualification data for qualified bioassay kits.
Read MoreCytokines play a crucial role in immune responses and have become important drug targets for treating inflammatory and autoimmune diseases.
Read MoreDiscovery and development of new molecules directed against validated pain targets is required to advance the treatment of pain disorders.…
Read MoreAs key mediators of immune responses, cytokines have emerged as major drug targets for inflammatory and autoimmune diseases. A significant…
Read MoreCheckpoint blockade antibodies are established cancer therapeutics. However, in recent years, agonistic antibodies have emerged as therapeutics not only for…
Read MoreIn this webinar, Eurofins DiscoverX and Latigo Therapeutics come together to present recent advances in ion channel drug discovery focusing…
Read MoreIn this webinar, Eurofins DiscoverX and Latigo Therapeutics come together to present recent advances in ion channel drug discovery focusing…
Watch NowCase studies on the use of cell-based assays that monitor receptor dimerization and signaling reporter activation targeting IL-12, IL-23, IL-15,…
Read MoreDiscover valuable insights on breakthroughs, innovative strategies, and cell-based approaches for immunotherapeutic discovery and development.
Read MoreDiscover valuable insights on breakthroughs, innovative strategies, and cell-based approaches for immunotherapeutic discovery and development.
Read More